|
Orthologous residues
|
|
EGFR (human): Y1092‑p, EGFR (mouse): Y1092‑p, EGFR (rat): Y1091‑p, EGFR (pig): Y1091‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), A293T ('renal, embryonic'), COS (fibroblast), HBEC3 (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human, monkey
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
gefitinib
|
|
EGFR (human)
|
|
decrease
|
Iressa does not inhibit phosphorylation of T790M mutant
|
|
|
|